220 related articles for article (PubMed ID: 18385064)
41. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
[TBL] [Abstract][Full Text] [Related]
42. [Effects of transforming growth factor-β2 on transdifferentiation, extracellular matrix synthesis and connective tissue growth factor expression of human lens epithelium cells].
Pei C; Ma B; Kang QY; Qin L; Zhang XL; Cui LJ
Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):822-8. PubMed ID: 24330933
[TBL] [Abstract][Full Text] [Related]
43. Effect of compressive force on the expression of MMPs, PAs, and their inhibitors in osteoblastic Saos-2 cells.
Mitsui N; Suzuki N; Koyama Y; Yanagisawa M; Otsuka K; Shimizu N; Maeno M
Life Sci; 2006 Jul; 79(6):575-83. PubMed ID: 16516240
[TBL] [Abstract][Full Text] [Related]
44. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
[TBL] [Abstract][Full Text] [Related]
45. Characterisation of TGF-beta2 signalling and function in a human lens cell line.
Wormstone IM; Tamiya S; Eldred JA; Lazaridis K; Chantry A; Reddan JR; Anderson I; Duncan G
Exp Eye Res; 2004 Mar; 78(3):705-14. PubMed ID: 15106950
[TBL] [Abstract][Full Text] [Related]
46. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1998-2003. PubMed ID: 12714635
[TBL] [Abstract][Full Text] [Related]
47. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.
Kita T; Hata Y; Kano K; Miura M; Nakao S; Noda Y; Shimokawa H; Ishibashi T
Diabetes; 2007 Jan; 56(1):231-8. PubMed ID: 17192487
[TBL] [Abstract][Full Text] [Related]
49. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
51. Elasticity-dependent modulation of TGF-β responses in human trabecular meshwork cells.
Han H; Wecker T; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2889-96. PubMed ID: 21282571
[TBL] [Abstract][Full Text] [Related]
52. The pathogenic role of transforming growth factor-β2 in glaucomatous damage to the optic nerve head.
Fuchshofer R
Exp Eye Res; 2011 Aug; 93(2):165-9. PubMed ID: 20708611
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial-Targeted Antioxidants Attenuate TGF-β2 Signaling in Human Trabecular Meshwork Cells.
Rao VR; Lautz JD; Kaja S; Foecking EM; Lukács E; Stubbs EB
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3613-3624. PubMed ID: 31433458
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of tissue inhibitor of metalloproteinases-3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase-2.
Liu W; Furuichi T; Miyake M; Rosenberg GA; Liu KJ
J Neurosci Res; 2007 Mar; 85(4):829-36. PubMed ID: 17279554
[TBL] [Abstract][Full Text] [Related]
55. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
[TBL] [Abstract][Full Text] [Related]
56. Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells.
Liu FY; Xiao L; Peng YM; Duan SB; Liu H; Liu YH; Ling GH; Yuan F; Chen JX; Fu X; Zhu JL
Chin Med J (Engl); 2007 Feb; 120(3):231-6. PubMed ID: 17355828
[TBL] [Abstract][Full Text] [Related]
57. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.
Zhou XD; Xiong MM; Tan FK; Guo XJ; Arnett FC
Arthritis Rheum; 2006 Dec; 54(12):3885-9. PubMed ID: 17133596
[TBL] [Abstract][Full Text] [Related]
58. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
[TBL] [Abstract][Full Text] [Related]
59. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
60. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
